Podcasts Science Vital Science (Re)programming Stem Cells for Drug Development

(Re)programming Stem Cells for Drug Development

Published: April 19, 2022, 8 a.m.

Mark Kotter, Founder and CEO of bit.bio, discusses technology to \u201creprogram\u201d stem cells.